Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide
Titel:
Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide
Auteur:
Kelaidi, C. Park, S. Brechignac, S. Mannone, L. Vey, N. Dombret, H. Aljassem, L. Stamatoullas, A. Adès, L. Giraudier, S. de Botton, S. Raynaud, S. Lepelley, P. Picard, F. Leroux, G. Daniel, M.T. Bouscary, D. Dreyfus, F. Fenaux, P.